CDK4/6 inhibitors in breast cancer: spotting the difference
| dc.contributor.author | Pérez García, José Manuel | |
| dc.contributor.author | Cortés Castán, Javier | |
| dc.contributor.author | Llombart Cussac, Antonio | |
| dc.date.accessioned | 2022-06-22T16:18:10Z | |
| dc.date.available | 2022-06-22T16:18:10Z | |
| dc.date.issued | 2021 | |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 87.244 JCR (2021) Q1, 1/297 Biochemistry & Molecular Medicine | spa |
| dc.description.impact | 24.161 SJR (2021) Q1, 2/274 Biochemistry, Genetics and Molecular Biology (miscellaneous) | spa |
| dc.description.impact | No data IDR 2021 | spa |
| dc.description.sponsorship | Sin financiación | spa |
| dc.identifier.citation | Pérez-García, J. M., Cortés, J., & Llombart-Cussac, A. (2021). CDK4/6 inhibitors in breast cancer: spotting the difference. Nature Medicine, 27(11), 1868–1869. https://doi.org/10.1038/s41591-021-01570-9 | spa |
| dc.identifier.doi | 10.1038/s41591-021-01570-9 | |
| dc.identifier.issn | 1078-8956 | |
| dc.identifier.issn | 1546-170X | |
| dc.identifier.uri | http://hdl.handle.net/11268/11371 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.rights.accessRights | restricted access | spa |
| dc.subject.other | Neoplasias de la mama | spa |
| dc.subject.other | Metástasis de la neoplasia | spa |
| dc.subject.other | Antineoplásicos | spa |
| dc.subject.unesco | Cáncer | spa |
| dc.subject.unesco | Tratamiento médico | spa |
| dc.title | CDK4/6 inhibitors in breast cancer: spotting the difference | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | d8744cdc-311f-4ac5-afd5-fd6a05d6adc8 | |
| relation.isAuthorOfPublication.latestForDiscovery | d8744cdc-311f-4ac5-afd5-fd6a05d6adc8 |